Sensex
82,215.61 profit arw 429.87 (0.53%)
Nifty
25,189.60 profit arw 120.40 (0.48%)
Nasdaq
18,355.20 profit arw -497.09 (-2.64%)
logo img

GET IN TOUCH

GET IN TOUCH

Refresh Captcha
Equity

As on : 04-Sep-2025
Hot Pursuit
04-Sep-2025     12:22

Epigral CFO Sanjay Jain steps down

In a regulatory filing, the company said that Jain's resignation will be effective from the close of business hours on 30 September 2025.

Epigral is primarily engaged in manufacturing and selling of Chlor Alkali & its Derivatives.

The company's consolidated net profit surged 87.1% to Rs 160.69 crore despite 6.9% decline in revenue from operations to Rs 606.54 crore in Q1 FY26 over Q1 FY25.

Shares of Epigral shed 0.67% to Rs 1,785 on the BSE.

Powered by Capital Market - Live News

INDIAN INDICES

Sensex

82,215.61 429.87 (0.53%)

Nifty

25,189.60 120.40 (0.48%)

GLOBAL INDICES

USD

NA

NASDAQ
HANG SENG

26,446.57 58.40(0.22%)